Author

A. Orban

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Organism:plant (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

J. Popovici· 2 shared J. Sattabongkot· 2 shared A. A. Ruberto· 1 shared A. C. Winnicki· 1 shared A. Harupa-Chung· 1 shared A. K. Chatterjee· 1 shared A. M. Vaughan· 1 shared A. N. Malachin· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. Popovici

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages

A. C. Winnicki, C. L. King, J. Bosch, A. N. Malachin, L. L. Carias, Y. Skomorovska-Prokvolit, W.-H. Tham, M. H. Dietrich, J. Popovici, W. Roobsoong, J. G. Beeson, J. Sattabongkot, L. M. Yeoh, D. H. Opi, L. B. Feufack-Donfack, , B. K. Wilder

The paper isolates a human monoclonal antibody that targets Plasmodium vivax AMA1, blocking both pre-erythrocytic and blood stage infections.

bioRxiv · Feb 7, 2024 · PreprintImmunology

A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites

S. P. Maher, M. A. Bakowski, A. Vantaux, E. L. Flannery, C. Andolina, M. Gupta, Y. Antonova-Koch, M. Argomaniz, C.-M. Monica, C. Brice, A. T. Chao, A. K. Chatterjee, W. T. Cheng, E. Chuenchob, C. A. Cooper, , McNama

The paper identifies epigenetic inhibitors active against Plasmodium vivax hypnozoites through drug repurposing screens, showing epigenetic pathways are critical for hypnozoite quiescence.

bioRxiv · Jan 31, 2023 · PreprintCell Biology